+208.0%
RDDT vs GSK
+25.8%
+182.2%
-61.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1990-01-01 to 2026-09-10.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +6.1% | -1.0% | +7.1% | +5.8% |
| 7D | -0.4% | -5.4% | +5.0% | -2.0% |
| 30D | -0.5% | -4.6% | +4.1% | -1.7% |
| 3M | -9.8% | -5.1% | -4.7% | -10.7% |
| 6M | +15.8% | -11.4% | +27.2% | +12.5% |
| YTD | -32.4% | +0.7% | -33.1% | -31.4% |
| 1Y | -40.0% | +23.0% | -63.1% | -35.4% |
| All | +208.0% | +25.8% | +182.2% | +218.7% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1990-01-01 to 2026-09-10: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1990-01-01 to 2026-09-10 analysis · Full analysis span regression · 6 months rolling